Key Documents

View All Documentation

2853

Eosin B Solution

Name: Eosin B Solution
Brand: SIGMA

0.1% aqueous solution

Select a Size

Change View

About This Item

NACRES:

NA.47

PubChem Substance ID:

24856870

UNSPSC Code:

41116121

MDL number:

MFCD00005041

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Quality Level

500

form

solution

IVD

for in vitro diagnostic use

concentration

0.1%

application(s)

hematology
histology

storage temp.

room temp

SMILES string

[Na+].[Na+].[O-]C(=O)c1ccccc1C2=C3C=C(C(=O)C(Br)=C3Oc4c(Br)c([O-])c(cc24)[N+]([O-])=O)[N+]([O-])=O

InChI

1S/C20H8Br2N2O9.2Na/c21-14-16(25)11(23(29)30)5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(24(31)32)17(26)15(22)19(10)33-18(9)14;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2

InChI key

GYYTYUGGVBYJHE-UHFFFAOYSA-L

Related Categories

Clinical & Diagnostics

Hematology Stains

Tissue Diagnostics

Application

Used as a counterstain in Sigma Procedure 285 for Fetal Hemoglobin.

Other Notes

Eosin B, 0.1%, aqueous solution. Sodium azide, 0.1% added as preservative

Storage Class

12 - Non Combustible Liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Information

监管及禁止进口产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.

Nilay S Sethi et al.

Nature genetics, 52(2), 219-230 (2020-02-07)

Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study

New Protein-Coated Silver Nanoparticles: Characterization, Antitumor and Amoebicidal Activity, Antiproliferative Selectivity, Genotoxicity, and Biocompatibility Evaluation.

Lucía Margarita Valenzuela-Salas et al.

Pharmaceutics, 13(1) (2021-01-13)

Nanomaterials quickly evolve to produce safe and effective biomedical alternatives, mainly silver nanoparticles (AgNPs). The AgNPs' antibacterial, antiviral, and antitumor properties convert them into a recurrent scaffold to produce new treatment options. This work reported the full characterization of a

Antibodies to post-translationally modified insulin in type 1 diabetes.

Rocky Strollo et al.

Diabetologia, 58(12), 2851-2860 (2015-09-10)

Insulin is the most specific beta cell antigen and a potential primary autoantigen in type 1 diabetes. Insulin autoantibodies (IAAs) are the earliest marker of beta cell autoimmunity; however, only slightly more than 50% of children and even fewer adults

Global Trade Item Number

SKU	GTIN
1372609025	04065267204482
1372601000	04065267204468
1372769025	04065267205113
1372609010	04065267204475
1032520250	04022536040844
B4429-1KG	04061835542857
B4429-100G	04061833429655
B7535-25G	04061833441909
B7535-500G	04061833441916
B7535-100G	04061833441893
B9754-500G	04061833443965
B9754-1KG	04061833443941
391335-100GM	04055977190106
391335-1KG	04055977190090
RDD013-500G	04061836828431
RDD013-100G	04061836828417
14879-100G-F	04061838738059
V900866-500G	04061833625262
V900866-100G	04061833615188
1032520025	04022536040837
1372760100	04065267205083
1372600100	04065267204451

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service